Nicotine Menthe Sans Sucre, Édulcorée Au Xylitol Eg Labo

Nicotine, the active ingredient in Nicotine Menthe Sans Sucre, Édulcorée Au Xylitol Eg Labo, is a nicotine replacement therapy presented as an oral formulation for buccal use. It is intended to aid adults who are trying to quit tobacco smoking by reducing withdrawal symptoms and cravings.

GNH USA supplies Nicotine Menthe Sans Sucre, Édulcorée Au Xylitol Eg Labo as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. The product complies with EU regulatory standards and is distributed under strict quality controls.

Nicotine is used as a nicotine replacement therapy to address tobacco‑related dependence.

- Smoking cessation: helps adult smokers gradually reduce nicotine intake and manage cravings. - Nicotine dependence: provides controlled nicotine delivery to alleviate withdrawal symptoms. - Tobacco use disorder: supports behavioral change by delivering nicotine without tobacco smoke.

Oral nicotine products can be associated with a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects: - Mouth irritation or tingling - Nausea or upset stomach - Headache - Dizziness - Altered taste sensation

Serious or Rare Side Effects: - Allergic reaction (rash, swelling, anaphylaxis) - Severe mouth ulceration or bleeding - Cardiovascular events such as arrhythmia or hypertension (rare)

Before using this nicotine replacement product, consider the following safety measures.

- Cardiovascular assessment: avoid use in recent myocardial infarction or uncontrolled hypertension. - Pregnancy and lactation: safety not established, consult a healthcare professional before use. - Allergy screening: discontinue if signs of hypersensitivity appear. - Concurrent nicotine products: do not combine with other nicotine replacement therapies. - Children safety: keep out of reach of children to prevent accidental ingestion. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nicotine may interact with several medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Warfarin: nicotine may increase anticoagulant effect; monitor INR closely. - Insulin or oral hypoglycemics: nicotine can affect glucose control; dosage adjustments may be needed.

Moderate Interactions (Monitor Closely): - Caffeine: nicotine may enhance stimulant effects; observe for jitteriness. - Monoamine oxidase inhibitors (MAOIs): potential additive sympathomimetic effects. - Antihypertensive agents: nicotine may counteract blood‑pressure‑lowering actions; monitor blood pressure.